oa SA Pharmaceutical Journal - New product focus : drug info

Volume 77, Issue 4
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Rivaroxaban (Xarelto®) is a new oral anticoagulant that was recently registered in South Africa. It is the first of two new orally administered anticoagulants poised to change anticoagulation practices by offering improvements over the current standard of care, such as fixed oral dosing and no need for routine monitoring.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error